NARI - Inari Medical Inc Debt to Book Capitalization Ratio

Corporate company logo of Inari Medical, Inc. (NARI)

Inari Medical, Inc. (NARI) generates revenue from the supply of FlowTriever and ClotTriever systems for mechanical thrombectomy. Its primary customers are radiologists and clinics that utilize catheters for safe vascular treatment. The history of the total debt-to-equity ratio demonstrates financial stability, with the value maintained at 0.08. However, competitive pressure and pricing demands from hospital networks remain key risk factors.

Inari Medical, Inc. - NARI Debts to Book Capitalization (period 07/04/2022 - 03/01/2025)
Flagship merchandise of Inari Medical Corp

Inari Medical, Inc. (NARI) demonstrates high financial resilience driven by stable demand for venous procedure systems. The debt-to-book capitalization ratio measures the proportion of borrowed capital relative to equity, determining the level of financial leverage. A decrease in this metric indicates a minimization of credit risks and independence from external loans. Predictable cash flows allow the company to effectively optimize its liability structure. Such a strategy strengthens the fundamental margin of safety and supports the long-term stability of share prices.

Competitors of Inari Medical, Inc.

DXCM: Debts to Book Capitalization|penumbrainc.com - Debts to Book Value|Debt to Book Capitalization Ratio Novanta (NOVT)|HAE - Debt to Net Assets Ratio|INSP: Debts to Book Capitalization|PRCT (Procept) - Debts to Book Capitalization|Debt to Book Capitalization Ratio CONMED Corporation CNMD|Debts to Book Capitalization Ratio pulsebiosciences.com|InMode - Debts to Book Capitalization|Debts to Book Value Picard Medical Corp PMI|Debt to Book Value SRDX (Surmodics Corp)|SENS - Debts to Book Capitalization|Debt to Book Value NeuroPace, Inc. NPCE|TCMD - Debt to Book Capital|SANUWAVE - Debts to Book Capitalization|Outset Medical Inc (OM) - Debts to Net Assets|Debts to Book Capitalization ELMD|Debt to Book Value LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Debt to Book Value|Debt to Net Assets Ratio PROF (profoundmedical.com)|Baird Medical - Debt to Book Capitalization Ratio|Debt to Book Value EDAP TMS SA EDAP|APYX (Bovie Medical) - Debts to Book Capitalization|ICCM - Debts to Book Value|Debts to Book Capitalization pulmonx.com|TELA Bio (TELA) - Debt to Book Value Ratio|CTSO: Debts to Book Capitalization|Debts to Net Assets Sensus Healthcare Inc|Debts to Book Capitalization ZYXI (Zynex Inc)|Debt to Book Value electrocore.com (ECOR)|Debts to Book Capitalization RBOT (Vicarious Surgical)|Inspira Technologies Oxy B.H.N. Ltd. - Debts to Book Capitalization|ICU - Debt to Book Capitalization Ratio|IRIDEX Corporation (IRIX) - Debt to Book Capitalization Ratio|Debt to Book Value ibs.inc INBS|Beyond Air (XAIR) - Debt to Net Assets Ratio|Debts to Book Capitalization PFSA (Profusa Inc)|Debts to Book Value SSKN|GCTK: Debt to Book Capitalization Ratio|Debt to Net Assets NanoVibronix Inc. NAOV|Debt to Book Value VERO (Venus Concept Corp)|Debts to Book Capitalization Nuwellis Corp NUWE|Debts to Book Capitalization AEMD (Aethlon Medical)|ASXC: Debts to Net Assets|Debt to Book Capitalization Ratio Avinger (AVGR)|BSGM (biosig.com) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio CUTR|Debt to Book Value Know Labs Corporation|Nevro Corp. - Debts to Book Capitalization|Debts to Book Value RSLS (reshapelifesciences.com)|SILK - Debt to Book Capitalization Ratio